Skip to content
The Future of joint Repair Logo
  • Joint Surface Lesions
  • Agili-C™
  • Clinical Study
    • Sites
  • Publications
  • Professionals
  • Videos
  • News
  • EU
  • ISR
Loading...


  • Latest News & Events

Newsmonimono2018-10-11T14:12:02+00:00
7
2022

Bioventus Completes CartiHeal Acquisition July 12, 2022

3
2022

FDA approves CartiHeal’s Implant for the Treatment of Cartilage and Osteochondral Defects March 30, 2022

8
2021

CartiHeal Announces Pivotal Study Results Demonstrate Agili-C™ Superiority to Microfracture and Debridement for the Treatment of Cartilage and Osteochondral Defects August 3, 2021

10
2020

CartiHeal Receives FDA “Breakthrough Device Designation” for the novel Agili-C Implant October 12, 2020

07
2020

Bioventus Makes $15 Million Equity Investment in CartiHeal with an Agreed Option Structure to Acquire Company Upon Milestone Achievements July 17, 2020

12
2019

CartiHeal announces enrollment completion for the Agili-C™ clinical study December 20, 2019

12
2019

CartiHeal Announces Positive Interim Analysis Results of Agili-C™ IDE Study December 10, 2019

10
2019

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Maryland October 16, 2019

08
2019

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedure in Texas August 29, 2019

08
2019

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures at Hospital for Special Surgery (HSS), New York, NY August 7, 2019

06
2019

CartiHeal Enrolls the 200th Patient in Its Pivotal Clinical Study in San Diego, CA June 12, 2019

06
2019

CartiHeal’s Agili-C™ Implant Enhances In-vitro Osteogenic Differentiation of Human Bone Marrow-derived Mesenchymal Stem Cells June 2, 2019

05
2019

CartiHeal Performs First Agili-C™ Cartilage Repair Implantation Procedures in the US West Coast May 8, 2019

05
2019

First Patient in New England Treated With the Agili-C™ Implant at CartiHeal’s Pivotal Study May 2, 2019

  • Home Page
  • Joint Surface Lesions
  • Agili-C™
  • Clinical Study
  • Sites
  • Professionals
  • Videos
  • News
  • Privacy policy

Footer text

CAUTION: Federal (United States) law restricts this device to sale by or on the order of a physician – as stated in the IFU

Indications for Use © Copyright 2017, CartiHeal, Inc. All rights reserved.
Site by Pearlcom
Bioventus Completes CartiHeal Acquisition

 
Learn more about Bioventus

 
Read Press Release here

CAUTION:

This website is intended only for US patients and healthcare professionals.
The Agili-C is an investigational device. Limited by Federal (United States) law to investigational use.

This site uses cookies

Provided that you have accepted the use of cookies, CartiHeal will use the “cookies” to facilitate the use of this site. Cookies are bits of text that are placed on your computer’s hard drive when you visit certain websites. CartiHeal will only use temporary Cookies for the purpose of redirecting users to their respective territory website [i.e. US, OUS, Israel] and for the purpose of displaying alerts and disclaimers required by law. please read our privacy policy